| Alan D Flanagan, MD | |
|
923 Lexington Ave, Fort Smith, AR 72901-4943 | |
| (479) 709-7350 | |
| (479) 709-7355 |
| Full Name | Alan D Flanagan |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 38 Years |
| Location | 923 Lexington Ave, Fort Smith, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780672170 | NPI | - | NPPES |
| 100069610A | Medicaid | OK | |
| 123373001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | R4469 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Choctaw Nation Health Services Authority | Talihina, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Choctaw Nation Of Oklahoma | 1759294838 | 204 |
News Archive
A study published in the journal Science provides support for a new-and still controversial-understanding of the immune system. The research was conducted by collaborators in the U.S. and Europe, including Robert Cramer, PhD, an assistant professor of microbiology and immunology at the Geisel School of Medicine and member of the Dartmouth Lung Biology Center, and Kelly Shepherdson, PhD, at the time a graduate student in Cramer's lab.
A new poll conducted for the Canadian Medical Association (CMA) shows that while Canadians recognize the urgency of the federal government tackling the deficit in next week's budget, they do not want it to come at the expense of health care.
CARLINA Technologies, a biotechnology company specializing in the development of nanomedicines, today announces the signing of a partnership agreement with Atlangram for the development of innovative pharmaceutical forms of antibiotics for the targeting of osteoarticular infectious diseases.
VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced today that it has received U.S. Food and Drug Administration approval for M-Vu CAD for mammography version 3.1. Concurrently, VuCOMP is releasing an update to its CAD station which includes the ability to process additional standard screening views.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
› Verified 1 days ago
| Entity Name | Choctaw Nation Of Oklahoma |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659347623 PECOS PAC ID: 1759294838 Enrollment ID: O20031106000326 |
News Archive
A study published in the journal Science provides support for a new-and still controversial-understanding of the immune system. The research was conducted by collaborators in the U.S. and Europe, including Robert Cramer, PhD, an assistant professor of microbiology and immunology at the Geisel School of Medicine and member of the Dartmouth Lung Biology Center, and Kelly Shepherdson, PhD, at the time a graduate student in Cramer's lab.
A new poll conducted for the Canadian Medical Association (CMA) shows that while Canadians recognize the urgency of the federal government tackling the deficit in next week's budget, they do not want it to come at the expense of health care.
CARLINA Technologies, a biotechnology company specializing in the development of nanomedicines, today announces the signing of a partnership agreement with Atlangram for the development of innovative pharmaceutical forms of antibiotics for the targeting of osteoarticular infectious diseases.
VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced today that it has received U.S. Food and Drug Administration approval for M-Vu CAD for mammography version 3.1. Concurrently, VuCOMP is releasing an update to its CAD station which includes the ability to process additional standard screening views.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alan D Flanagan, MD Po Box 402330, Atlanta, GA 30384-2330 Ph: (479) 709-7399 | Alan D Flanagan, MD 923 Lexington Ave, Fort Smith, AR 72901-4943 Ph: (479) 709-7350 |
News Archive
A study published in the journal Science provides support for a new-and still controversial-understanding of the immune system. The research was conducted by collaborators in the U.S. and Europe, including Robert Cramer, PhD, an assistant professor of microbiology and immunology at the Geisel School of Medicine and member of the Dartmouth Lung Biology Center, and Kelly Shepherdson, PhD, at the time a graduate student in Cramer's lab.
A new poll conducted for the Canadian Medical Association (CMA) shows that while Canadians recognize the urgency of the federal government tackling the deficit in next week's budget, they do not want it to come at the expense of health care.
CARLINA Technologies, a biotechnology company specializing in the development of nanomedicines, today announces the signing of a partnership agreement with Atlangram for the development of innovative pharmaceutical forms of antibiotics for the targeting of osteoarticular infectious diseases.
VuCOMP, Inc., leading developer of advanced computer vision systems for the detection of breast cancer, announced today that it has received U.S. Food and Drug Administration approval for M-Vu CAD for mammography version 3.1. Concurrently, VuCOMP is releasing an update to its CAD station which includes the ability to process additional standard screening views.
Seattle Genetics, Inc. today announced the initiation of a phase Ib clinical trial evaluating SGN-75 in combination with everolimus (Afinitor) for patients with advanced metastatic renal cell carcinoma (RCC).
› Verified 1 days ago
John Joseph Weisse, MD PH D Surgery Medicare: Not Enrolled in Medicare Practice Location: 5622 Rogers Ave, Fort Smith, AR 72903 Phone: 479-452-4400 Fax: 479-452-4406 | |
Sarahrose Schneider Webster, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1500 Dodson Ave Ste 175, Fort Smith, AR 72901 Phone: 479-573-7940 Fax: 479-573-7941 | |
Dr. David W Hunton, MD Surgery Medicare: Medicare Enrolled Practice Location: 2717 S 74th St, Fort Smith, AR 72903 Phone: 479-573-3101 Fax: 479-573-3102 | |
Dr. Peter Cmorej, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1500 Dodson Ave Ste 175, Fort Smith, AR 72901 Phone: 479-573-7940 Fax: 479-573-7941 | |
Dr. Stephen J Seffense, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 7001 Rogers Ave, Fort Smith, AR 72903 Phone: 479-274-5100 Fax: 479-274-5179 | |
Dr. Ryan Christopher Banning, MD Surgery Medicare: Medicare Enrolled Practice Location: 1500 Dodson Ave Ste 175, Fort Smith, AR 72901 Phone: 479-573-7940 Fax: 479-573-7941 | |
Amanda G. Chisum-price, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 923 Lexington Ave, Fort Smith, AR 72901 Phone: 479-709-7350 Fax: 479-709-7355 |